Development of a Blood Glucose Control System for Postoperative Diabetics

糖尿病术后血糖控制系统的开发

基本信息

  • 批准号:
    14550444
  • 负责人:
  • 金额:
    $ 1.98万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2003
  • 项目状态:
    已结题

项目摘要

Today, surgical operations on elderlies and diabetics are often performed. After surgical operations, they would sometimes come down with hyperglycemia, which is called "postoperative diabetes." Since this might result in infection, anastomic failure, or other complications, insulin is infused by medical staffs. The infusion rate of insulin has to be accurately adjusted, because patients would fall into hypoglycemia if an excessive amount of insulin is infused, and because blood glucose level would not become low enough if a sufficient amount of insulin is not infused. However, it is not easy to manipulate the insulin infusion rate to maintain the blood glucose within the desired range because the response of blood glucose to insulin is widely varying during a few days after surgery.In this research, we have studied 1)the model of the blood glucose regulatory system of postoperative diabetics, and 2)a blood glucose control method for postoperative diabetics. The obtained results are as follows.●From the results of animal experiments, Karlsburg model is the most appropriate model of blood glucose regulatory system in the time-invariant case among the representative models proposed in the past.●The blood glucose response of postoperative diabetics can be modeled as a second order state equation with a dead-time.●The change of the blood glucose response with time to insulin can be represented as the change of the gain of the blood glucose regulatory system.●The state-predictive controller with an auto-tuning function developed for blood glucose control of diabetics without a knowledge of individual parameters is effective as the controller for postoperative diabetics.
如今,经常进行有关老年人和糖尿病患者的外科手术。手术手术后,有时会因高血糖症而降低,这被称为“术后糖尿病”。由于这可能导致感染,吻合术衰竭或其他并发症,因此胰岛素被医务人员注入。必须对胰岛素的输注率进行准确调节,因为如果胰岛素含量过多,患者将陷入低血糖,并且由于未注入足够量的胰岛素,血糖水平不会变得足够低。然而,操纵胰岛素输注率并不容易维持在所需范围内的血糖,因为在手术后的几天内,血糖对胰岛素的反应在很大程度上变化。获得的结果如下。●从动物实验的结果中,卡尔斯堡模型是在过去不变的情况下,在过去的代表性模型中,最合适的血糖调节系统模型。●术后糖尿病患者的血糖反应可以与静止的时间相对于死亡的时间来模仿eSsection play wister wiste wiste wiste wiste wiste wiste wiste wiste wiste wiste wiste wiste wiste wiste wiste wiste wiste wiste。血糖调节系统的增益。●具有自动调节功能的国家预测控制器,不知道糖尿病患者的血糖控制,而无需了解各个参数,作为术后糖尿病患者的控制者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ARAKI Mituhiko其他文献

ARAKI Mituhiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ARAKI Mituhiko', 18)}}的其他基金

Oxygen administration method for heart failure patients with sleep-disordered breathing
心力衰竭睡眠呼吸障碍患者的供氧方法
  • 批准号:
    16360211
  • 财政年份:
    2004
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a Phacoemulsifier with an Intracameral Pressure Control Function
具有前房压力控制功能的超声乳化器的研制
  • 批准号:
    13555119
  • 财政年份:
    2001
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
On an Automatic Intravenous Anesthesia Control System
静脉麻醉自动控制系统的探讨
  • 批准号:
    11650445
  • 财政年份:
    1999
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a Blood Pressure Control System for Wide Use
开发广泛使用的血压控制系统
  • 批准号:
    10555143
  • 财政年份:
    1998
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Research on Multirate Digital Control Systems
多速率数字控制系统研究
  • 批准号:
    60550294
  • 财政年份:
    1985
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
  • 批准号:
    82370820
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
胰岛素样多肽和甲壳动物高血糖激素对凡纳滨对虾糖代谢的协同调控作用
  • 批准号:
    32273102
  • 批准年份:
    2022
  • 资助金额:
    54.00 万元
  • 项目类别:
    面上项目
胰岛素样多肽和甲壳动物高血糖激素对凡纳滨对虾糖代谢的协同调控作用
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
基于肠道微生态途径探讨花色苷对糖尿病前期患者血糖稳态和胰岛素敏感性的影响及差异性应答的机制
  • 批准号:
    82073533
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
乌鸡强胰岛素耐受性及血糖稳态调节机制
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目

相似海外基金

Racial Disparities in Sleep, Circadian Rhythm, and Glucoregulation Among Individuals Post-Coronary Artery Bypass Surgery
冠状动脉搭桥手术后个体在睡眠、昼夜节律和血糖调节方面的种族差异
  • 批准号:
    10750187
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Randomized controlled trial of continuous glucose monitoring compared to point of care glucose testing following hospital discharge on 12-week diabetic foot ulcer healing rates
连续血糖监测与出院后护理点血糖测试对 12 周糖尿病足溃疡愈合率的随机对照试验
  • 批准号:
    10727731
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Integrated Electrochemical Aptamer Based Platforms for the Point-of-Care and Continuous Monitoring of Clinically Relevant Analytes
基于集成电化学适体的平台,用于临床相关分析物的护理点和连续监测
  • 批准号:
    10538257
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
Integrated Electrochemical Aptamer Based Platforms for the Point-of-Care and Continuous Monitoring of Clinically Relevant Analytes
基于集成电化学适体的平台,用于临床相关分析物的护理点和连续监测
  • 批准号:
    10705637
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
Angiogenic hydrogel composites for microvascular integration of organoid grafts
用于类器官移植物微血管整合的血管生成水凝胶复合材料
  • 批准号:
    10395412
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了